✓ Last verified: January 30, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Greenbrook TMS NeuroHealth Centers in Huntington Beach is part of a national network offering TMS therapy and Spravato (esketamine) nasal spray for treatment-resistant depression. As one of the largest dedicated TMS and esketamine providers in the country, Greenbrook brings standardized, evidence-based protocols to their Orange County location, giving patients access to two FDA-approved neuromodulation and ketamine-based treatments.
| Review Scores | ⭐ Positive patient feedback |
| Location | Huntington Beach, California |
| Address | 18700 Main Street, Suite 108, Huntington Beach, CA 92648 |
| Phone | (855) 940-4867 |
| Website | greenbrooktms.com |
| Treatments | TMS (Transcranial Magnetic Stimulation), Spravato (Esketamine) Nasal Spray |
| Conditions Treated | Treatment-Resistant Depression, Major Depressive Disorder |
| Cost | Contact clinic for pricing; Spravato and TMS often covered by insurance |
| Insurance | Most major insurance plans accepted |
| KAP Available? | No — Spravato nasal spray protocol (not IV ketamine) |
| Clinical Lead | Greenbrook TMS clinical team |
💡 No clinic-specific pricing posted? See our ketamine therapy cost guide for typical pricing ranges by treatment type and insurance pathways.
HealingMaps Take: Greenbrook’s Huntington Beach location offers Orange County patients access to both TMS and Spravato (esketamine), the only FDA-cleared ketamine-based treatment for depression. The national network’s standardized protocols and broad insurance acceptance make it an accessible entry point for patients exploring alternatives to traditional antidepressants. While Greenbrook doesn’t offer IV ketamine infusions, their Spravato program provides a regulated, insurance-friendly ketamine-based option worth considering.
Market Position: Greenbrook TMS is a verified ketamine provider in the Beach metro on HealingMaps — one of 1,473 clinics we have mapped and tracked across 3,142 U.S. counties.
⚠ FDA-cleared indications for TMS therapy: treatment-resistant major depressive disorder (MDD), obsessive-compulsive disorder (OCD, Deep TMS only), anxious depression, short-term smoking cessation, and adolescent MDD (ages 15–21). Use of TMS for other conditions including PTSD, bipolar depression, fibromyalgia, and other indications is off-label — not currently FDA-cleared for those specific indications. Discuss your condition with the clinic to understand insurance coverage and clinical evidence.
Industry pricing reference. Greenbrook TMS has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine Infusion | $350–$650/session | ✓ |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ |
| TMS (transcranial magnetic stimulation) | $200–$300/session, often insurance-covered | ✓ |
| IM Ketamine | $250–$400/injection | — |
| KAP (with integrated talk therapy) | $400–$1,200/session | — |
| At-home oral troches | $150–$300/month | — |
This 2-question summary is matched to the protocols and conditions Greenbrook TMS treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Greenbrook TMS offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Greenbrook TMS treats depression via Spravato (FDA-cleared for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
TMS therapy is also available at this clinic, alongside ketamine and Spravato. Unlike cash-pay ketamine, TMS is covered by most major insurance plans for treatment-resistant depression. TMS is FDA-cleared for treatment-resistant depression (since 2008), OCD via Deep TMS, anxious depression, and adolescent MDD ages 15–21. This clinic uses BrainsWay Deep TMS, the only TMS device with standalone FDA clearance for OCD via the H7 coil. Read our complete guide to TMS therapy for FDA-cleared conditions, device differences, insurance coverage by carrier, and what to expect at your first appointment. Browse verified TMS clinics in our directory.
View all REMS-certified Spravato clinics in California and across the United States.
Save 40%+ on Your Medical Supplies
GPO-level pricing negotiated through Pipeline Medical, exclusively for Healing Health Alliance members. Find out how much we can save your clinic — no obligation, no contracts.
Leave a Reply